The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic buildup of protein, which can contribute to Alzheimer's and related ...

A UTA, University of California–San Francisco study explores why some nerve cells are more vulnerable to neurodegeneration ...

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...

A new Northwestern Medicine study publishing in Nature Medicine suggests a promising alternative to previous attempts to ...

For the early detection of Alzheimer's disease, so-called p-tau proteins in the blood are not as disease-specific as ...

The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...